Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed

The data, from the American College of Cardiology PINNACLE (Practice Innovation and Clinical Excellence) registry between 2008 and 2012, showed that 61.8% of patients with moderate-to-high stroke risk received anticoagulant therapy with either warfarin or newer direct oral anticoagulants (DOACs).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2016-12, Vol.68 (22), p.2492-2492
Main Authors: Brown, Joshua D., PharmD, MS, Shewale, Anand R., MS, Dherange, Parinita, MD, Talbert, Jeffery C., PhD
Format: Article
Language:English
Subjects:
Anticoagulants
Atrial Fibrillation
Cardiac arrhythmia
Cardiology
Cardiovascular
Coagulation
Humans
Internal Medicine
Stroke
Thrombolytic Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The data, from the American College of Cardiology PINNACLE (Practice Innovation and Clinical Excellence) registry between 2008 and 2012, showed that 61.8% of patients with moderate-to-high stroke risk received anticoagulant therapy with either warfarin or newer direct oral anticoagulants (DOACs).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.06.082